In this work we show that MAPTau can quantify and characterize tau aggregates with high specificity and sensitivity in disease‐derived samples, including brain tissue homogenates and serum extracts, revealing differences in tau aggregate number between tauopathy disease‐derived and age‐matched control samples. The gene discussed is MAPT; the disease is tauopathy.